Медицинская литература. Новинки

 

 

 

 

 

 

Холецистолитиаз: современное состояние проблемы

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Гальперин Э.И., Ветшев П.С. Руководство по хирургии желчных путей. 2е изд. М.: Издательский дом Видар-М, 2009.
2. Chen C.H., Huang M.H., Yang J.C. Prevalence and risk factors of
gallstone disease in an adult population of Taiwan: an epidemiological survey // J. Gastroenterol. Hepatol. 2006. V. 21. P. 1737–1743.
3. Marschall H.U., Katsika D., Rudling M. The genetic background
of gallstone formation: an update // Biochem. Biophys. Res.
Commun. 2010. V. 396. N1. P. 58–62.
4. Вихрова Т.В. Билиарный сладж, клиническое значение. Основные подходы к диагностике и лечению // Мед. диагностика. Управление и качество. 2008. №3. С. 56–58.
5. Kratzer W., Walcher T., Arnold F. Gallstone prevalence and risk
factors for gallstone disease in an urban population of children and
adolescents // Z. Gastroenterol. 2010. V. 48. N6. P. 683–687.
6. Миронов А.С. Выбор метода лечения холецистолитиаза //
Хирургия. 2000. №5. С. 7–9.
7. Тюргалин Я.Л. Закономерности морфофункциональных
нарушений в желчном пузыре и печени в патогенезе холестеринового холелитиаза: Автореф. дис. … канд. мед. наук.
Иркутск. 2000.
8. Гальперин Э.И., Волкова Н.В. Заболевания желчных путей
после холецистэктомии. М.: Медицина. 1998.
9. Ильченко А.А. Постхолецистэктомический синдром: клинические аспекты проблемы // Consilium Medicum. Приложение. 2006. Т. 8. №2.
10. Фромм Г. Камни желчного пузыря и билиарная боль: оперировать или не оперировать? // Рос. журн. гастроэнтерол.,
гепатол., колопроктол. 1998. №4. С. 82–85.
11. Ермолов А.С. Хирургия желчнокаменной болезни // Анн.
хирургии. 1998. №3. С. 13–24.
12. Минушкин О.Н., Масловский Л.В. Диагностика и лечение
функциональных расстройств билиарного тракта // Рус.
мед. журн. 2010. Т. 18. №5. С. 277–283.
13. Festi D., Dormi A., Capodicasa S. Incidence of gallstone disease
in Italy: results from a multicenter, populationbased Italian
study (the MICOL project) // Wld J. Gastroenterol. 2008. V. 14
(34). P. 5282–5289.
14. Keus F., Broeders I.A., van Laarhoven C.J. Gallstone disease:
Surgical aspects of symptomatic cholecystolithiasis and acute
cholecystitis // Best Pract. Res. Clin. Gastroenterol. 2006. V. 20.
N6. P. 1031–1051.
15. Anwar A.H., Ahmed Q.A., Bradpiece H.A. Removing Symptomatic Gallstones at their First Emergency Presentation // Ann.
R. Coll. Surg. Engl. 2008. V. 90. N5. P. 394–397.
16. Cheruvu C.V., Eyre*Brook I.A. Consequences of prolonged wait
before gallbladder surgery // Ann. R. Coll. Surg. Engl. 2002.
V. 84. N1. P. 20–22.
17. Gurusamy K.S., Samraj K., Fusai G. Early versus delayed laparoscopic cholecystectomy for biliary colic // Cochr. Database Syst.
Rev. 2008. V. 8. N4. CD007196.
18. Gracie W.A., Ransohoff D.R. The natural history of silent gallstones: the innocent gallstone is not a myth // N. Engl. J. Med.
1982. V. 307. P. 798–800.
19. Schirmer B.D., Winters K.L., Edlich R.F. Cholelithiasis and
cholecystitis // J. Long Term Eff. Med. Implants. 2005. V. 15.
N3. P. 329–338.
20. Shrikhande S.V., Barreto S.G., Singh S. Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause! // Eur. J. Surg.
Oncol. 2010. V. 36. N6. P. 514–519.
21. Nath G., Gulati A.K., Shukla V.K. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder //
Wld J. Gastroenterol. 2010. V. 16. N43. P. 5395–5404.
22. Han H.S., Cho J.Y., Yoon Y.S. Preoperative inflammation is a
prognostic factor for gallbladder carcinoma // Br. J. Surg. 2011.
V. 98. N1. P. 111–116.
23. Feng Z., Chen J., Wei H. et al. The risk factor of gallbladder cancer: hyperplasia of mucous epithelium caused by gallstones associates with p16/CyclinD1/CDK4 pathway // Exp. Mol. Pathol.
2011. V. 91. N2. P. 569–577.
24. Csendes A., Becerra M., Rojas J. et al. Number and size of stones
in patients with asymptomatic and symptomatic gallstones and
gallbladder carcinoma: a prospective study of 592 cases // J.
Gastrointest. Surg. 2000. V. 4. N5. P. 481–485.
25. Venneman N.G., Buskens E., Besselink M.G. Small gallstones are
associated with increased risk of acute pancreatitis: potential
benefits of prophylactic cholecystectomy? // Am. J. Gastroenterol. 2005. V. 100. N11. P. 2540–2550.
26. Barkun J., Woo D., Marcaccio M. Small gallstones may increase
the risk of pancreatitis; is there a benefit for a prophylactic cholecystecomy? // Can. J. Surg. 2007. V. 50. N1. P. 62–65.
27. Liew P.L., Wang W., Lee Y.C. et al. Gallbladder disease among
obese patients in Taiwan // Obes Surg. 2007. V. 17. N3. P. 383–390.
28. Kasprzak A., Malkowski W., Biczysko W. et al. Histological alterations of gallbladder mucosa and selected clinical data in young
patients with symptomatic gallstones // Pol. J. Pathol. 2011.
V. 62. N1. P. 41–49.
29. Hoffmann C., Trebing G., Meyer L. et al. Value and sensitivity of
abdominal ultrasound in preoperative histologic diagnosis before
laparoscopic cholecystectomy // Zentralbl Chir. 1998. V. 123
(Suppl 2). P. 89–91.
30. Hokama A., Kishimoto K., Ihama Y. et al. Gallbladder
Dysfunction Diagnosed by Cholescintigraphy with a Fatty Meal
// Gut Liver. 2010. V. 4. N4. P. 556–557.
31. Ziessman H.A., Tulchinsky M., Lavely W.C. et al. Sincalide-stimulated cholescintigraphy: a multicenter investigation to determine optimal infusion methodology and gallbladder ejection
fraction normal values // J. Nucl. Med. 2010. V. 51. N2.
P. 277–281.
32. Орлова Ю.Н. Сократительная функция желчного пузыря по
данным ультразвукового метода исследования // Рос. гастроэнтерол. журн. 1998. №4. С.88–89.
33. Mutirangura P., Siwawetkul W. Gallbladder contraction capacity
in response to liquid fatty meal: a real time ultrasonographic
study // J. Med. Assoc. Thai. 1996. V. 79 (10). P. 640–647.
34. Pallotta N. Ultrasonography in the assessment of gallbladder
motor activity // Dig. Liver Dis. 2003. V. 35. P. 67–69.
35. Cerci S.S., Ozbek F.M., Cerci C. Gallbladder function and
dynamics of bile flow in asymptomatic gallstone disease // Wld
J. Gastroenterol. 2009. V. 15. N22. P. 2763–2767.
36. Huang S.M., Yao C.C., Pan H. Pathophysiological significance of
gallbladder volume changes in gallstone diseases // Wld J.
Gastroenterol. 2010. V. 16. N34. P. 4341–4347.
37. Pauletzki J., Cicala M., Holl J. Correlation between gall bladder
fasting volume and postprandial emptying in patients with gall
stones and healthy controls // Gut. 1993. V. 34. N10.
P. 1443–1447.
38. Larsen T.K., Qvist N. The influence of gallbladder function on
the symptomatology in gallstone patients, and the outcome after
cholecystectomy or expectancy // Dig. Dis. Sci. 2007. V. 52.
P. 760–763.
39. Stokes C.S., Krawczyk M., Lammert F. Gallstones: environment,
lifestyle and genes // Dig. Dis. Sci. 2011. V. 29. N2. P. 191–201.
40. Yakoob J., Khan M.R., Abbas Z. et al. Helicobacter pylori: association with gall bladder disorders in Pakistan // Br. J. Biomed.
Sci. 2011. V. 68. N2. P. 59–64.
41. Huang W., Bansode R.R., Xie Y. et al. Disruption of the murine
protein kinase Cbeta gene promotes gallstone formation and
alters biliary lipid and hepatic cholesterol metabolism // J. Biol.
Chem. 2011. V. 286. N26. P. 22795–22805.
42. Sauerbruch T. Guidelines of the German Society of Gastroenterology for the treatment of gallstones // Z. Arztl. Fortbild.
Qualitatssich. 2002. V. 96. N4. P. 222–226.
43. van Erpecum K.J. Pathogenesis of cholesterol and pigment gallstones: an update // Clin. Res. Hepatol. Gastroenterol. 2011.
V. 35. N4. P. 281–287.
44. Venneman N.G., van Erpecum K.J. Pathogenesis of gallstones //
Gastroenterol. Clin. N. Am. 2010. V. 39. N2. P. 171–183.
45. Jüngst D., Gussmann E., Zündt B. et al. Solubility of cholesterol
in the crystalfree gallbladder bile of gallstone patients // J. Lab.
Clin. Med. 2004. V. 144. N3. P. 134–140.
46. Kasprzak A., Malkowski W., Helak*Lapaj C. et al. Polysaccharides and mucin 5AC (MUC5AC) expression in gallbladder
mucosa of young patients with gallstones as evaluated by spatial
visualization and quantification // Folia Histochem Cytobiol.
2010. V. 48. N4. P. 646–657.
47. Крутиков С.Н., Окулов В.И. Использование инфракрасной
спектрофотометрии желчи. М., 1991.
48. Sharma B.C., Agarwal D.K., Dhiman R.K. et al. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect
of bile acid therapy // Gastroenterology. 1998. V. 115. N1.
P. 124–128.
49. Тюргалин Я.Л. Закономерности морфофункциональных нарушений в желчном пузыре и печени в патогенезе холестеринового холелитиаза: Автореф. дис. … канд. мед. наук.
Иркутск, 2000.
50. Grattagliano I., Wang D.Q., Di Ciaula A. et al. Biliary proteins
and their redox status changes in gallstone patients // Eur.
J. Clin. Invest. 2009. V. 39. N11. P. 986–992.
51. Abeysuriya V., Deen K.I., Navarathne N.M. Biliary microlithiasis, sludge, crystals, microcrystallization, and usefulness of
assessment of nucleation time // Hepatobil. Pancr. Dis. Int.
2010. V. 9. N3. P. 248–253.
52. Шабалин В.Н., Шатохина С.Н. Морфология биологических
жидкостей человека. М.: Хризостом, 2001.
53. Инюткина Н.В., Шатохина С.Н., Шабалин В.Н. Особенности структуропостроения желчи у лиц пожилого возраста. //
Сб. науч. трудов 2й Всерос. научн.–практ. конф. М., 2001.
С. 85–86.
54. Ильченко А.А., Вихрова Т.В., Орлова Ю.Н. Билиарный сладж.
Современный взгляд на проблему // Гепатология. 2003. №6.
С. 20–25.
55. Мехтиев С.Н., Гриневич В.Б., Кравчук Ю.А., Богданов Р.Н.
Билиарный сладж: нерешeнные вопросы // Лечащий врач.
2007. №6. С. 24–28.
56. Запруднов А.М., Царькова О.Н., Харитонова Л.А. Клиникопатогенетическое значение билиарного сладжа как начальной стадии желчнокаменной болезни в детском возрасте //
Педиатрия. 2010. Т. 89. №2. С. 40–45.
57. Ko C.W., Schulte S.J., Lee S.P. Biliary sludge is formed by modification of hepatic bile by the gallbladder mucosa // Clin.
Gastroenterol. Hepatol. 2005. V. 3. N7. P. 672–678.
58. Маев И.В., Дичева Т.Д., Бурагина Т.А. Диагностика и лечение билиарного сладжа у больных язвенной болезнью // Рос.
журн. гастроэнтерол., гепатол., колопроктол. 2007. №4.
59. Григорьева И.Н. Билиарный сладж. // Рос. журн. гастроэнтерол., гепатол., колопроктол. 2009. №3.
60. Hofmann A.F. Bile acid science (cholanology) at the dawn
of a new millenium; past progress and challenges for the future.
Bile acids in hepatobiliary disease / Ed. by Manns M. P. et al.
1998. P. 262–270.
61. Jüngst C., Kullak*Ublick G.A., Jüngst D. Gallstone disease:
microlithiasis and sludge // Best. Pract. Res. Clin. Gastroenterol. 2006. V. 20. N6. P. 1053–1062.
62. Sheffield K.M., Ramos K.E., Djukom C.D. et al. Implementation
of a critical pathway for complicated gallstone disease: translation of populationbased data into clinical practice // J. Am.
Coll. Surg. 2011. V. 212. N5. P. 835–843.
63. Payen J.L., Muscari F., Vibert E. et al. Biliary lithiasis // Presse
Med. 2011. V. 40 N6. P. 567–580.
64. Ford J.A., Soop M., Du J. et al. Systematic review of intraoperative cholangiography in Cholecystectomy // Br. J. Surg. 2012.
V. 99. N2. P. 160–167.
65. Venara A., Mucci S., Roch A. et al. Visceral surgeon and intraoperative cholangiography: Survey about French Wild West surgeons // J. Visc. Surg. 2011. V. 148. N5. P. 385–391.
66. Tabone L.E., Sarker S., Fisichella P.M. et al. To 'gram or not'?
Indications for intraoperative cholangiogram // Surgery. 2011.
V. 150. N4. P. 810–819.
67. Ардасенов Т.Б., Фрейдович Д.А., Паньков А.Г. и др. Дооперационная диагностика скрытого холедохолитиаза // Анн.
xир. гепатол. 2011. Т. 16. № 2.
68. Нишневич Е.В., Столин А.В., Шелепов И.В., Прудков М.И.
О целесообразности холангиографии у больных острым
холециститом // Анн. xир. гепатол. 2009. T. 14. № 4.
69. Cociorvei A., Calu V. Laparoscopic ultrasound in biliary
diseases // Chirurgia (Bucur). 2011. V. 106. N3. P. 353–358.
70. Hodgett S.E., Hernandez J.M., Morton C.A. et al. Laparoendoscopic single site (LESS) cholecystectomy // J. Gastrointest.
Surg. 2009. V. 13. N2. P. 188–192.
71. Roberts K.E., Solomon D., Duffy A.J. et al. Single-incision laparoscopic cholecystectomy: a surgeon's initial experience with 56
consecutive cases and a review of the literature // J. Gastrointest.
Surg. 2010. V. 14. N3. P. 506–510.
72. Chow A., Purkayastha S., Aziz O. et al. Single-incision laparoscopic surgery for cholecystectomy: a retrospective comparison
with 4port laparoscopic cholecystectomy // Arch. Surg. 2010.
V. 145. N12. P. 1187–1191.
73. Antoniou S.A., Pointner R., Granderath F.A. Single-incision
laparoscopic cholecystectomy: a systematic review // Surg.
Endosc. 2011. V. 25. N2. P. 367–377.
74. Ahmed K., Wang T.T., Patel V.M. et al. The role of single-incision
laparoscopic surgery in abdominal and pelvic surgery: a systematic review // Surg. Endosc. 2011. V. 25. N2. P. 378–396.
75. Kilian M., Raue W., Menenakos C. et al. Transvaginal-hybrid vs.
singleportaccess vs. “conventional” laparoscopic cholecystectomy: a prospective observational study. // Langenbecks Arch.
Surg. 2011. V. 396. N5. P. 709–715.
76. Zornig C., Mofid H., Siemssen L. et al. Transvaginal NOTES
hybrid cholecystectomy: feasibility results in 68 cases with midterm followup // Endoscopy. 2009. V. 41. N5. P. 391–394.
77. Hensel M., Schernikau U., Schmidt A. et al. Surgical outcome and
midterm followup after transvaginal NOTES hybrid cholecystectomy: analysis of a prospective clinical series // J. Laparoendosc. Adv. Surg. Tech. A. 2011. V. 21. N2. P. 101–106.
78. Van den Boezem P.B., Kruyt F.M., Stommel M.W. et al. Cholecystectomy without visible scars: the transvaginal method //
Ned. Tijdschr. Geneeskd. 2011. V. 155. N44. P. A3617.
79. Targarona E.M., Maldonado E.M., Marzol J.A. et al. Natural orifice transluminal endoscopic surgery: The transvaginal route
moving forward from Cholecystectomy // Wld J. Gastrointest.
Surg. 2010. V. 2. N6. P. 179–186.
80. Bucher P., Ostermann S., Pugin F. et al. Female population perception of conventional laparoscopy, transumbilical LESS, and
transvaginal NOTES for Cholecystectomy // Surg. Endosc.
2011. V. 25. N7. P. 2308–2315.
81. Прудков И.Д., Ренева Т.Г., Ходаков В.В. Отдаленные результаты лапароскопической холецистолитотомии у больных
желчнокаменной болезнью / Физиол. и патол. гепатобилиарной системы. Томск. 1980. С. 134–135.
82. Дедерер Ю.М., Крылова Н.П., Устинов Г.Г. Желчнокаменная
болезнь. М.: Медицина, 1983.
83. De Caluwé D., Akl U., Corbally M. Cholecystectomy versus
cholecystolithotomy for cholelithiasis in childhood: long-term
outcome // J. Pediatr. Surg. 2001. V. 36. N10. P. 1518–1521.
84. Zou Y.P., Du J.D., Li W.M. Gallstone recurrence after successful
percutaneous cholecystolithotomy: a 10year followup of 439
cases // Hepatobil. Pancr. Dis. Int. 2007. V. 6. N2. P. 199–203.
85. Elías P,J., Delgado A.R., Martínez*Pardo N.G. Must we change
the surgical treatment of gallstones? // Cir. Pediatr. 2008. V. 21.
N2. P. 96–99.
86. Roqués J.L., Pruneda R.R., S>anchez J. Cholecystolithotomy: first
middlelong term results of our series // Cir. Pediatr. 2009. V. 22.
N3. P. 153–156.
87. Минушкин О.Н., Бурдина Е.Г. Желчнокаменная болезнь
(о механизмах камнеобразования и современных аспектах
лечения) // Клин. мед. 1990. Т. 68. №3. С. 35–42.
88. Майстренко Н.А., Нечай И.А. Гепатобилиарная хирургия:
Руководство для врачей. СПб.: Спецная литра, 1999.
89. Гребнев А.Л., Геня Л.П. Отдаленные результаты холелитической терапии у больных желчнокаменной болезнью препаратами хено- и урсодезоксихолевой кислот // Клин. мед.
1991. №6. C. 63–66.
90. Schoefield L.J., Lachin J.M. The steering commitee and the
national cooperative gallstone study // Am. Int. Med. 1981.
V. 95. N3. P. 257–282.
91. Bertolotti M., Gabbi C., Anzivino C. Nuclear receptors as potential molecular targets in cholesterol accumulation conditions:
insights from evidence on hepatic cholesterol degradation and
gallstone disease in humans // Cur. Med. Chem. 2008. V. 15.
N22. P. 2271–2284.
92. Portincasa P., Di Ciaula A., Wang H.H. Medicinal treatments of
cholesterol gallstones: old, current and new perspectives // Cur.
Med. Chem. 2009. V. 16. N12. P. 1531–1542.
93. Ahmed M.H. Ezetimbe as potential treatment for cholesterol
gallstones: the need for clinical trials // Wld J. Gastroenterol.
2010. V. 16. N13. P. 1555–1557.
94. Di Ciaula A., Wang D.Q., Wang H.H. Targets for current pharmacologic therapy in cholesterol gallstone disease //
Gastroenterol. Clin. N. Am. 2010. V. 39. N2. P. 245–264.
95. Keizman D., Goldiner I., Leikin*Frenkel A. Innovations in the
medical treatment of gallstones and fatty liver: FABACs (Fatty
Acid Bile Acid Conjugates) // Harefuah. 2008. V. 147. N4.
P. 344–349, 372, 373.
96. Paumgartner G., Sauter G.H. Extracorporeal shock wave
lithotripsy of gallstones: 20th anniversary of the first treatment //
Eur. J. Gastroenterol. Hepatol. 2005. V. 17. N5. P. 525–527.
97. Tudyka J., Kratzer W., Maier C. The relation between biliary
lipids, nucleation time, and number of gallbladder stones after
percutaneous gallbladder puncture // Scand. J. Gastroenterol.
1994. V. 29. N9. P. 844–888.
98. Plaisier P.W., van der Hul R.L., den Toom R. Gallstone lithotripsy: the Rotterdam experience // Hepatogastroenterology. 1994.
V. 41. N3. P. 260–262.
99. Tudyka J., Wechsler J.G., Kratzer W. Gallstone recurrence after
successful dissolution therapy // Dig. Dis. Sci. 1996. V. 41. N2.
P. 235–241.
100.Shoda J., Ueda T., Ikegami T. Increased biliary group II phospholipase A2 and altered gallbladder bile in patients with multiple cholesterol stones // Gastroenterology. 1997. V. 112. N6.
P. 2036–2047.

Gallbladder Stones: Modern Condition of the Problem

Keywords: